Janssen Study: Now Enrolling for Ages 13-35
Currently, there are no approved treatments specifically for autism spectrum disorder (ASD). That’s why we need your help. We are enrolling adolescents and young adults with ASD ages 13 through 35 to participate in a study at SARRC. The purpose of this research is to determine the effectiveness of an investigational medication in improving the most common behavioral symptoms of ASD.